Global and Japan Oncology Drugs Market Size, Status and Forecast 2021-2027

Global and Japan Oncology Drugs Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Drugs Market Perspective (2016-2027)
2.2 Oncology Drugs Growth Trends by Regions
2.2.1 Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncology Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Oncology Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Oncology Drugs Industry Dynamic
2.3.1 Oncology Drugs Market Trends
2.3.2 Oncology Drugs Market Drivers
2.3.3 Oncology Drugs Market Challenges
2.3.4 Oncology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Drugs Players by Revenue
3.1.1 Global Top Oncology Drugs Players by Revenue (2016-2021)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncology Drugs Revenue
3.4 Global Oncology Drugs Market Concentration Ratio
3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2020
3.5 Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Drugs Product Solution and Service
3.7 Date of Enter into Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drugs Breakdown Data by Type
4.1 Global Oncology Drugs Historic Market Size by Type (2016-2021)
4.2 Global Oncology Drugs Forecasted Market Size by Type (2022-2027)
5 Oncology Drugs Breakdown Data by Application
5.1 Global Oncology Drugs Historic Market Size by Application (2016-2021)
5.2 Global Oncology Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncology Drugs Market Size (2016-2027)
6.2 North America Oncology Drugs Market Size by Type
6.2.1 North America Oncology Drugs Market Size by Type (2016-2021)
6.2.2 North America Oncology Drugs Market Size by Type (2022-2027)
6.2.3 North America Oncology Drugs Market Size by Type (2016-2027)
6.3 North America Oncology Drugs Market Size by Application
6.3.1 North America Oncology Drugs Market Size by Application (2016-2021)
6.3.2 North America Oncology Drugs Market Size by Application (2022-2027)
6.3.3 North America Oncology Drugs Market Size by Application (2016-2027)
6.4 North America Oncology Drugs Market Size by Country
6.4.1 North America Oncology Drugs Market Size by Country (2016-2021)
6.4.2 North America Oncology Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Oncology Drugs Market Size (2016-2027)
7.2 Europe Oncology Drugs Market Size by Type
7.2.1 Europe Oncology Drugs Market Size by Type (2016-2021)
7.2.2 Europe Oncology Drugs Market Size by Type (2022-2027)
7.2.3 Europe Oncology Drugs Market Size by Type (2016-2027)
7.3 Europe Oncology Drugs Market Size by Application
7.3.1 Europe Oncology Drugs Market Size by Application (2016-2021)
7.3.2 Europe Oncology Drugs Market Size by Application (2022-2027)
7.3.3 Europe Oncology Drugs Market Size by Application (2016-2027)
7.4 Europe Oncology Drugs Market Size by Country
7.4.1 Europe Oncology Drugs Market Size by Country (2016-2021)
7.4.2 Europe Oncology Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size (2016-2027)
8.2 Asia-Pacific Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncology Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncology Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Drugs Market Size (2016-2027)
9.2 Latin America Oncology Drugs Market Size by Type
9.2.1 Latin America Oncology Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Oncology Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Oncology Drugs Market Size by Type (2016-2027)
9.3 Latin America Oncology Drugs Market Size by Application
9.3.1 Latin America Oncology Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Oncology Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Oncology Drugs Market Size by Application (2016-2027)
9.4 Latin America Oncology Drugs Market Size by Country
9.4.1 Latin America Oncology Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Oncology Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Market Size (2016-2027)
10.2 Middle East & Africa Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncology Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Drugs Introduction
11.1.4 Roche Revenue in Oncology Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Drugs Introduction
11.2.4 Celgene Revenue in Oncology Drugs Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Drugs Introduction
11.3.4 Novartis Revenue in Oncology Drugs Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Drugs Introduction
11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Drugs Introduction
11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Drugs Introduction
11.8.4 Pfizer Revenue in Oncology Drugs Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Drugs Introduction
11.9.4 Amgen Revenue in Oncology Drugs Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Oncology Drugs Introduction
11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Oncology Drugs Introduction
11.11.4 AbbVie Revenue in Oncology Drugs Business (2016-2021)
11.11.5 AbbVie Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Oncology Drugs Introduction
11.12.4 Takeda Revenue in Oncology Drugs Business (2016-2021)
11.12.5 Takeda Recent Development
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Oncology Drugs Introduction
11.13.4 Astellas Revenue in Oncology Drugs Business (2016-2021)
11.13.5 Astellas Recent Development
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Oncology Drugs Introduction
11.14.4 Ipsen Revenue in Oncology Drugs Business (2016-2021)
11.14.5 Ipsen Recent Development
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Oncology Drugs Introduction
11.15.4 Sanofi Revenue in Oncology Drugs Business (2016-2021)
11.15.5 Sanofi Recent Development
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Oncology Drugs Introduction
11.16.4 Bayer Revenue in Oncology Drugs Business (2016-2021)
11.16.5 Bayer Recent Development
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Oncology Drugs Introduction
11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2016-2021)
11.17.5 Biogen Idec Recent Development
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Drugs Introduction
11.18.4 Teva Revenue in Oncology Drugs Business (2016-2021)
11.18.5 Teva Recent Development
11.18 Otsuka
.1 Otsuka Company Details
.2 Otsuka Business Overview
.3 Otsuka Oncology Drugs Introduction
.4 Otsuka Revenue in Oncology Drugs Business (2016-2021)
.5 Otsuka Recent Development
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Oncology Drugs Introduction
11.20.4 Eisai Revenue in Oncology Drugs Business (2016-2021)
11.20.5 Eisai Recent Development
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Oncology Drugs Introduction
11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2016-2021)
11.21.5 Merck KGaA Recent Development
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Oncology Drugs Introduction
11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2016-2021)
11.22.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy (Biologic Therapy)
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Others
Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oncology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oncology Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Oncology Drugs Market Share by Regions (2016-2021)
Table 11. Global Oncology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Oncology Drugs Market Share by Regions (2022-2027)
Table 13. Oncology Drugs Market Trends
Table 14. Oncology Drugs Market Drivers
Table 15. Oncology Drugs Market Challenges
Table 16. Oncology Drugs Market Restraints
Table 17. Global Oncology Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Oncology Drugs Market Share by Players (2016-2021)
Table 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020)
Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Drugs Product Solution and Service
Table 24. Date of Enter into Oncology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Oncology Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Oncology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Oncology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Oncology Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Oncology Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Oncology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Oncology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Oncology Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Oncology Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oncology Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Oncology Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Oncology Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Oncology Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Oncology Drugs Product
Table 67. Roche Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Celgene Company Details
Table 70. Celgene Business Overview
Table 71. Celgene Oncology Drugs Product
Table 72. Celgene Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 73. Celgene Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Oncology Drugs Product
Table 77. Novartis Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Oncology Drugs Product
Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Oncology Drugs Product
Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Merck & Co. Company Details
Table 90. Merck & Co. Business Overview
Table 91. Merck & Co. Oncology Drugs Product
Table 92. Merck & Co. Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 93. Merck & Co. Recent Development
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Oncology Drugs Product
Table 97. AstraZeneca Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 98. AstraZeneca Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 102. Pfizer Recent Development
Table 103. Amgen Company Details
Table 104. Amgen Business Overview
Table 105. Amgen Oncology Drugs Product
Table 106. Amgen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 107. Amgen Recent Development
Table 108. Eli Lilly Company Details
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Oncology Drugs Product
Table 111. Eli Lilly Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 112. Eli Lilly Recent Development
Table 113. AbbVie Company Details
Table 114. AbbVie Business Overview
Table 115. AbbVie Oncology Drugs Product
Table 116. AbbVie Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 117. AbbVie Recent Development
Table 118. Takeda Company Details
Table 119. Takeda Business Overview
Table 120. Takeda Oncology Drugs Product
Table 121. Takeda Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 122. Takeda Recent Development
Table 123. Astellas Company Details
Table 124. Astellas Business Overview
Table 125. Astellas Oncology Drugs Product
Table 126. Astellas Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 127. Astellas Recent Development
Table 128. Ipsen Company Details
Table 129. Ipsen Business Overview
Table 130. Ipsen Oncology Drugs Product
Table 131. Ipsen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 132. Ipsen Recent Development
Table 133. Sanofi Company Details
Table 134. Sanofi Business Overview
Table 135. Sanofi Oncology Drugs Product
Table 136. Sanofi Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 137. Sanofi Recent Development
Table 138. Bayer Company Details
Table 139. Bayer Business Overview
Table 140. Bayer Oncology Drugs Product
Table 141. Bayer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 142. Bayer Recent Development
Table 143. Biogen Idec Company Details
Table 144. Biogen Idec Business Overview
Table 145. Biogen Idec Oncology Drugs Product
Table 146. Biogen Idec Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 147. Biogen Idec Recent Development
Table 148. Teva Company Details
Table 149. Teva Business Overview
Table 150. Teva Oncology Drugs Product
Table 151. Teva Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 152. Teva Recent Development
Table 153. Otsuka Company Details
Table 154. Otsuka Business Overview
Table 155. Otsuka Oncology Drugs Product
Table 156. Otsuka Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 157. Otsuka Recent Development
Table 158. Eisai Company Details
Table 159. Eisai Business Overview
Table 160. Eisai Oncology Drugs Product
Table 161. Eisai Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 162. Eisai Recent Development
Table 163. Merck KGaA Company Details
Table 164. Merck KGaA Business Overview
Table 165. Merck KGaA Oncology Drugs Product
Table 166. Merck KGaA Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 167. Merck KGaA Recent Development
Table 168. Gilead Sciences Company Details
Table 169. Gilead Sciences Business Overview
Table 170. Gilead Sciences Oncology Drugs Product
Table 171. Gilead Sciences Revenue in Oncology Drugs Business (2016-2021) & (US$ Million)
Table 172. Gilead Sciences Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Immunotherapy (Biologic Therapy) Features
Figure 5. Hormonal Therapy Features
Figure 6. Others Features
Figure 7. Global Oncology Drugs Market Share by Application: 2020 VS 2027
Figure 8. Blood Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Respiratory or Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Oncology Drugs Report Years Considered
Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Oncology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Oncology Drugs Market Share by Regions: 2020 VS 2027
Figure 18. Global Oncology Drugs Market Share by Regions (2022-2027)
Figure 19. Global Oncology Drugs Market Share by Players in 2020
Figure 20. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2020
Figure 22. Global Oncology Drugs Revenue Market Share by Type (2016-2021)
Figure 23. Global Oncology Drugs Revenue Market Share by Type (2022-2027)
Figure 24. North America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Oncology Drugs Market Share by Type (2016-2027)
Figure 26. North America Oncology Drugs Market Share by Application (2016-2027)
Figure 27. North America Oncology Drugs Market Share by Country (2016-2027)
Figure 28. United States Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Oncology Drugs Market Share by Type (2016-2027)
Figure 32. Europe Oncology Drugs Market Share by Application (2016-2027)
Figure 33. Europe Oncology Drugs Market Share by Country (2016-2027)
Figure 34. Germany Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Oncology Drugs Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Oncology Drugs Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Oncology Drugs Market Share by Region (2016-2027)
Figure 44. China Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Oncology Drugs Market Share by Type (2016-2027)
Figure 52. Latin America Oncology Drugs Market Share by Application (2016-2027)
Figure 53. Latin America Oncology Drugs Market Share by Country (2016-2027)
Figure 54. Mexico Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Oncology Drugs Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Oncology Drugs Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Oncology Drugs Market Share by Country (2016-2027)
Figure 60. Turkey Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 68. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 71. Amgen Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 72. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 73. AbbVie Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 74. Takeda Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 75. Astellas Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 76. Ipsen Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 77. Sanofi Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 78. Bayer Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 79. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 80. Teva Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 81. Otsuka Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 82. Eisai Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 83. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs